Thymoma
ORPHA:99867DiseaseNot applicableAdult
Фенотипы (HPO)37
Частый (30–79%)4
HP:0001824Weight loss
HP:0031378Abnormal lymphocyte proliferation
HP:0031409Abnormal lymphocyte physiology
HP:0100749Chest pain
Периодический (5–29%)12
HP:0001324Muscle weakness
HP:0001609Hoarse voice
HP:0001945Fever
HP:0002094Dyspnea
HP:0002664Neoplasm
HP:0002721Immunodeficiency
HP:0002960Autoimmunity
HP:0004313Decreased circulating antibody level
HP:0012735Cough
HP:0030166Night sweats
HP:0030208Acetylcholine receptor antibody positivity
HP:0045026Abnormality of the mediastinum
Очень редкий (1–4%)21
HP:0000099Glomerulonephritis
HP:0000707Abnormality of the nervous system
HP:0001370Rheumatoid arthritis
HP:0001909Leukemia
HP:0001915Aplastic anemia
HP:0002725Systemic lupus erythematosus
HP:0003326Myalgia
HP:0005560Imbalanced hemoglobin synthesis
HP:0007108Demyelinating peripheral neuropathy
HP:0007378Neoplasm of the gastrointestinal tract
HP:0012288Neoplasm of head and neck
HP:0012410Pure red cell aplasia
HP:0012539Non-Hodgkin lymphoma
HP:0031041Obstruction of the superior vena cava
HP:0100031Neoplasm of the thyroid gland
HP:0100279Ulcerative colitis
HP:0100324Scleroderma
HP:0100526Neoplasm of the lung
HP:0100527Neoplasia of the pleura
HP:0100614Myositis
HP:0100787Prostate neoplasm
Эпидемиология3
| Тип оценки | Класс распространённости | Среднее (на 100к) | Регион | Квалификация |
|---|---|---|---|---|
| Annual incidence | 1-9 / 1 000 000 | 0.14 | Europe | Value and class |
| Lifetime Prevalence | 1-9 / 100 000 | 1.22 | Europe | Value and class |
| Point prevalence | Unknown | — | Worldwide | Class only |
Лекарства и терапия
Источник: Open Targets Platform (в реальном времени)
Клинические исследования
Источник: ClinicalTrials.gov (в реальном времени)